Clinical Trial Update: A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 study investigating the antidepressant mechanism-of-action of Janssen's JNJ-42847922 in adults with major depress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JNJ-42847922

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED